Abstract:Background: The severity, progression, and outcomes of motor and non-motor symptoms in Parkinson's disease (PD) are quite variable. Following PD cohorts holds promise for identifying predictors of disease severity and progression. Methods: PD patients (N = 871) were enrolled at five sites. Enrollment occurred within 5 years of initial motor symptom onset. Disease progression was assessed annually for 2-to-10 years after onset. Group-based trajectory modeling was used to identify groups differing in disease progression. Models were developed for UPDRS-III scores, UPDRS-III tremor and bradykinesia-rigidity subscores, Hoehn & Yahr (H&Y) stage, Mini-Mental Status Exam (MMSE) scores, and UPDRS-III, H&Y and MMSE scores considered together. Predictors of trajectory-group membership were modeled simultaneously with the trajectories. Kaplan-Meier survival analysis evaluated survival free of PD outcomes. Results: The best fitting models identified three groups. One showed a relatively benign, slowly progressing trajectory (Group 1), a second showed a moderate, intermediately progressing trajectory (Group 2), and a third showed a more severe, rapidly progressing trajectory (Group 3). Stable trajectory-group membership occurred relatively early in the disease course, 5 years after initial motor symptom. Predictors of intermediate and more severe trajectory-group membership varied across the single variable models and the multivariable model jointly considering UPDRS-III, H&Y and MMSE scores. In the multivariable model, membership in Group 2 (28.4% of patients), relative to Group 1 (50.5%), was associated with male sex, younger age-at-onset, fewer education-years, pesticide exposure, absence of reported head injury, and akinetic/rigid subtype at initial presentation. Membership in Group 3 (21.3%), relative to Group 1, was associated with older age-at-onset, fewer education-years, pesticide exposure, and the absence of a tremor-predominant subtype at initial presentation. Persistent freezing, persistent falls, and cognitive impairment occurred earliest and more frequently in Group 3, later and less frequently in Group 2, and latest and least frequently in Group 1. Furthermore, autonomic complications, dysphagia, and psychosis occurred more frequently in Groups 2 and 3 than in Group 1. Conclusion: Modeling disease course using multiple objective assessments over an extended follow-up duration identified groups that more accurately reflect differences in PD course, prognosis, and outcomes than assessing single parameters over shorter intervals.

The progression trajectory of Bipolar Disorder: results from the application of a staging model over a ten-year observation

Bipolar disorder staging and the impact it has on its management: an update

Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force

Staging bipolar disorder: An alluring proposition

Rethinking the course of psychotic disorders: modelling long-term symptom trajectories

Applying a clinical staging model in patients affected by schizophrenia spectrum disorder

Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages

Integrating Polygenic Allele Burden Information and Phenomic Data to Characterize Complex Disease Trajectories in Severe Mental Illness

Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

Predictors of Functional Impairment in Bipolar Disorder: Results From 13 Cohorts From Seven Countries by the Global Bipolar Cohort Collaborative

Advances in Staging of schizophrenia. Development of an empirical staging model for schizophrenia.

Longitudinal inference of multiscale markers in psychosis: from hippocampal centrality to functional outcome

Predictors of Transition from Child and Adolescent Bipolar Not Otherwise Specified to Bipolar I Disorder, a Longitudinal 3.9-Year Study

Evidence for mood instability in patients with bipolar disorder: Applying multilevel hidden Markov modeling to intensive longitudinal ecological momentary assessment data.

The theory of bipolar disorder as an illness of accelerated aging: Implications for clinical care and research

Latent-state models for precision medicine

Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD study

Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder

A clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go?

Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment